Financhill
Sell
25

ERMAY Quote, Financials, Valuation and Earnings

Last price:
$5.45
Seasonality move :
-9.4%
Day range:
$5.45 - $5.51
52-week range:
$4.44 - $12.21
Dividend yield:
2.99%
P/E ratio:
105.33x
P/S ratio:
0.50x
P/B ratio:
1.04x
Volume:
5.8K
Avg. volume:
740
1-year change:
-50.66%
Market cap:
$1.6B
Revenue:
$3.2B
EPS (TTM):
$0.05
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $3.2B $4.4B $5.4B $3.5B $3.2B
Revenue Growth (YoY) -22.56% 36.59% 22.58% -34.59% -9.8%
 
Cost of Revenues $1.3B $1.4B $1.9B $1.5B $1.3B
Gross Profit $1.9B $2.9B $3.5B $2.1B $1.9B
Gross Profit Margin 60.31% 67.09% 65.39% 58.75% 58.44%
 
R&D Expenses $35.4M $24.8M $17.9M $47.6M $23.8M
Selling, General & Admin $1.1B -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.7B $2B $2.2B $2B $1.8B
Operating Income $272.9M $903.9M $1.3B $42.2M $75.8M
 
Net Interest Expenses $147.3M $137.2M $93.9M $120.2M $151.5M
EBT. Incl. Unusual Items -$58.2M $1.1B $1.3B $113.7M $44.4M
Earnings of Discontinued Ops. -$589.3M -$504M -$164.5M $6.5M --
Income Tax Expense $126.8M $116M $278.4M $95.3M $101.7M
Net Income to Company -$772M $431.9M $816.3M $19.5M -$56.3M
 
Minority Interest in Earnings $1.1M -$79.3M -$35.9M $98.5M $71.4M
Net Income to Common Excl Extra Items -$770.9M $352.6M $780.4M $118M $15.2M
 
Basic EPS (Cont. Ops) -$2.91 $1.23 $2.72 $0.41 $0.05
Diluted EPS (Cont. Ops) -$2.91 $1.23 $2.69 $0.41 $0.05
Weighted Average Basic Share $265.1M $285.7M $286.7M $285.9M $286.2M
Weighted Average Diluted Share $265.1M $286.9M $290.4M $289.4M $289.2M
 
EBITDA $569.9M $1.4B $1.9B $626.8M $396.1M
EBIT $91.4M $1.2B $1.4B $276.1M $232.7M
 
Revenue (Reported) $3.2B $4.4B $5.4B $3.5B $3.2B
Operating Income (Reported) $272.9M $903.9M $1.3B $42.2M $75.8M
Operating Income (Adjusted) $91.4M $1.2B $1.4B $276.1M $232.7M
Period Ending 2009-12-31 2010-12-31 2011-12-31 2012-12-31 2013-12-31
Revenue $2B $2.4B $2.3B $2.3B $2.2B
Revenue Growth (YoY) -- -- 13.36% -3.83% -2.29%
 
Cost of Revenues $1.6B $1.6B $1.7B $1.9B $1.9B
Gross Profit $368.6M $838.4M $542.9M $445.2M $339.6M
Gross Profit Margin 18.4% 34.85% 23.9% 19.24% 15.3%
 
R&D Expenses $25.8M $31.7M $33.7M $37.1M $34.4M
Selling, General & Admin $99M $105.8M $110.1M $127.2M $129.3M
Other Inc / (Exp) $8.6M $1.3M -$106.2M -- --
Operating Expenses $347.1M $296.2M $349.8M $420M $1B
Operating Income $21.5M $507.8M $181.4M $13.3M -$705.4M
 
Net Interest Expenses $17.2M $6.6M -- $11.9M $24.8M
EBT. Incl. Unusual Items $12.9M $502.5M $106.2M $1.3M -$730.1M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $55.9M $218.2M $75.1M -- -$71.5M
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings $31.6M -$251.3M -$46.6M -$17.2M $193.9M
Net Income to Common Excl Extra Items -$43M $117.7M -$15.5M -$15.9M -$464.8M
 
Basic EPS (Cont. Ops) -$0.28 $0.76 $0.30 -$0.06 -$1.77
Diluted EPS (Cont. Ops) -$0.28 $0.76 $0.30 -$0.06 -$1.77
Weighted Average Basic Share $262.8M $265.5M -- $262.5M $262.6M
Weighted Average Diluted Share $262.8M $265.5M -- $264.2M $262.6M
 
EBITDA $219.4M $629.5M $347.2M $190.8M $71.5M
EBIT $21.5M $507.8M $181.4M $13.3M -$705.4M
 
Revenue (Reported) $2B $2.4B $2.3B $2.3B $2.2B
Operating Income (Reported) $21.5M $507.8M $181.4M $13.3M -$705.4M
Operating Income (Adjusted) $21.5M $507.8M $181.4M $13.3M -$705.4M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $3.2B $4.3B $5.3B $3.5B $3.1B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $1.3B $1.4B $1.8B $1.5B $1.3B
Gross Profit $1.9B $2.9B $3.5B $2.1B $1.8B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $1.1B -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses $1.6B $2B $2.2B $2B $1.8B
Operating Income $293.3M $884.9M $1.3B $41.5M $74.2M
 
Net Interest Expenses $146.3M $137M $93.4M $120.4M $150.2M
EBT. Incl. Unusual Items -$9.3M $1B $1.3B $114M $43.3M
Earnings of Discontinued Ops. -- -$490.5M -$160.1M $6.7M --
Income Tax Expense $125.7M $115.6M $276.7M $95M $100.9M
Net Income to Company -$747.9M $425M $824.8M $20.1M -$56.4M
 
Minority Interest in Earnings -$263.4K -$77.7M -$38.7M $98.4M $70.9M
Net Income to Common Excl Extra Items -$748.1M $344.1M $785.5M $118.7M $14.5M
 
Basic EPS (Cont. Ops) -$2.82 $1.20 $2.74 $0.41 $0.05
Diluted EPS (Cont. Ops) -$2.82 $1.19 $2.71 $0.41 $0.05
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $141.4M $1.2B $1.4B $276.3M $229.6M
EBIT $141.4M $1.2B $1.4B $276.3M $229.6M
 
Revenue (Reported) $3.2B $4.3B $5.3B $3.5B $3.1B
Operating Income (Reported) $293.3M $884.9M $1.3B $41.5M $74.2M
Operating Income (Adjusted) $141.4M $1.2B $1.4B $276.3M $229.6M
Period Ending 2021-05-22 2022-05-22 2023-05-22 2024-05-22
Revenue -- -- -- -- --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues -- -- -- -- --
Gross Profit -- -- -- -- --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin -- -- -- -- --
Other Inc / (Exp) -- -- -- -- --
Operating Expenses -- -- -- -- --
Operating Income -- -- -- -- --
 
Net Interest Expenses -- -- -- -- --
EBT. Incl. Unusual Items -- -- -- -- --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -- -- -- -- --
Net Income to Company -- -- -- -- --
 
Minority Interest in Earnings -- -- -- -- --
Net Income to Common Excl Extra Items -- -- -- -- --
 
Basic EPS (Cont. Ops) -- -- -- -- --
Diluted EPS (Cont. Ops) -- -- -- -- --
Weighted Average Basic Share -- -- -- -- --
Weighted Average Diluted Share -- -- -- -- --
 
EBITDA -- -- -- -- --
EBIT -- -- -- -- --
 
Revenue (Reported) -- -- -- -- --
Operating Income (Reported) -- -- -- -- --
Operating Income (Adjusted) -- -- -- -- --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.8B $893.3M $1.2B $1.2B $656.6M
Short Term Investments $430.5M $438.2M $575.9M $577M $293.4M
Accounts Receivable, Net $428M $424.6M $395.7M $244.3M $225.8M
Inventory $1.1B $654.4M $776.4M $684.2M $720.1M
Prepaid Expenses $18.4M $5.7M $7.5M -- $4.2M
Other Current Assets -- -- -- -- --
Total Current Assets $4.2B $3.5B $4.3B $3.3B $2.5B
 
Property Plant And Equipment $2.9B $2.8B $2.6B $2.7B $3.1B
Long-Term Investments -- -- -- -- --
Goodwill $247.2M $233.2M $223.1M $205.6M $194.6M
Other Intangibles $191.9M $175.5M $179.1M $159.2M $158.2M
Other Long-Term Assets -- $1.1M -- -$2.2M $4.1B
Total Assets $7.9B $7.1B $7.7B $6.9B $6.7B
 
Accounts Payable $665.4M $456.3M $454.7M $491.9M $399.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $18.4M $14.7M $17.2M $19.9M $19.8M
Other Current Liabilities $123M $161.9M $144.8M $195.7M $264.3M
Total Current Liabilities $1.9B $2.4B $2.7B $1.9B $1.5B
 
Long-Term Debt $3.5B $1.8B $1.5B $1.7B $1.9B
Capital Leases -- -- -- -- --
Total Liabilities $6.7B $5.6B $5.3B $4.7B $4.5B
 
Common Stock $99.6M $99.6M $94.4M $97.3M $91.6M
Other Common Equity Adj -- -- -- -- --
Common Equity $891.7M $1.1B $1.9B $1.8B $1.5B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $286.6M $365.7M $497.6M $435.5M $726.3M
Total Equity $1.2B $1.5B $2.4B $2.2B $2.2B
 
Total Liabilities and Equity $7.9B $7.1B $7.7B $6.9B $6.7B
Cash and Short Terms $2.2B $1.3B $1.8B $1.8B $950M
Total Debt $3.8B $2.3B $2.1B $2.4B $2.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $1.8B $893.3M $1.2B $1.2B $656.6M
Short Term Investments $430.5M $438.2M $575.9M $577M $293.4M
Accounts Receivable, Net $428M $424.6M $395.7M $244.3M $225.8M
Inventory $1.1B $654.4M $776.4M $684.2M $720.1M
Prepaid Expenses $18.4M $5.7M $7.5M -- $4.2M
Other Current Assets -- -- -- -- --
Total Current Assets $4.2B $3.5B $4.3B $3.3B $2.5B
 
Property Plant And Equipment $2.9B $2.8B $2.6B $2.7B $3.1B
Long-Term Investments -- -- -- -- --
Goodwill $247.2M $233.2M $223.1M $205.6M $194.6M
Other Intangibles $191.9M $175.5M $179.1M $159.2M $158.2M
Other Long-Term Assets -- $1.1M -- -$2.2M $4.1B
Total Assets $7.9B $7.1B $7.7B $6.9B $6.7B
 
Accounts Payable $665.4M $456.3M $454.7M $491.9M $399.6M
Accrued Expenses -- -- -- -- --
Current Portion Of Long-Term Debt -- -- -- -- --
Current Portion Of Capital Lease Obligations $18.4M $14.7M $17.2M $19.9M $19.8M
Other Current Liabilities $123M $161.9M $144.8M $195.7M $264.3M
Total Current Liabilities $1.9B $2.4B $2.7B $1.9B $1.5B
 
Long-Term Debt $3.5B $1.8B $1.5B $1.7B $1.9B
Capital Leases -- -- -- -- --
Total Liabilities $6.7B $5.6B $5.3B $4.7B $4.5B
 
Common Stock $99.6M $99.6M $94.4M $97.3M $91.6M
Other Common Equity Adj -- -- -- -- --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $286.6M $365.7M $497.6M $435.5M $726.3M
Total Equity $1.2B $1.5B $2.4B $2.2B $2.2B
 
Total Liabilities and Equity $7.9B $7.1B $7.7B $6.9B $6.7B
Cash and Short Terms $2.2B $1.3B $1.8B $1.8B $950M
Total Debt $3.8B $2.3B $2.1B $2.4B $2.2B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$772M $431.9M $816.3M $19.5M -$56.3M
Depreciation & Amoritzation $478.5M $168M $515.7M $350.8M $163.4M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- $56.3M
Change in Inventories -- -- -- -- -$88.8M
Cash From Operations $352.9M $760.8M $1B $186.2M -$135.3M
 
Capital Expenditures -- -- $620.1M $996M $651.6M
Cash Acquisitions -- -- $39M -- --
Cash From Investing -$428.3M -$328.9M -$541M -$603M -$331.2M
 
Dividends Paid (Ex Special Dividend) -$4.6M -$4.7M -$75.9M -$108.3M -$46.5M
Special Dividend Paid
Long-Term Debt Issued $1.7B $142M $176.1M $1.5B $916.7M
Long-Term Debt Repaid -$524.2M -$1.4B -$419.7M -$1.2B -$543.3M
Repurchase of Common Stock -$4.6M -$9.5M -$7.4M -$10.8M -$5.4M
Other Financing Activities -$12.6M $20.1M $194M $271.7M -$260.8M
Cash From Financing $1.1B -$1.2B -$63.3M $291.2M -$13M
 
Beginning Cash (CF) $635M $1.7B $832.1M $1.2B $1.2B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1B -$783.3M $440.8M -$125.6M -$479.5M
Ending Cash (CF) $1.7B $933.5M $1.2B $1.2B $683M
 
Levered Free Cash Flow $352.9M $760.8M $425M -$809.8M -$786.9M
Period Ending 2009-06-30 2010-06-30 2011-06-30 2012-06-30 2013-06-30
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation $200M $164.5M -- $148M $189M
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable $160.6M -$187.7M -- -$21.1M -$41.7M
Change in Inventories $426.8M -$57.3M -- -$32.3M -$52.1M
Cash From Operations -$57.8M $351M $377.6M $63.4M $84.7M
 
Capital Expenditures $209.9M $140.1M $255.6M $379.4M $354.6M
Cash Acquisitions -- -- -- -$1.2M --
Cash From Investing -$105.6M -$132.8M -$255.6M -$395.6M -$189M
 
Dividends Paid (Ex Special Dividend) -$191.6M -$57.3M -$267.1M -$73.4M -$44.3M
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $181.7M $19.5M -- $119.4M $325.9M
Long-Term Debt Repaid -$131M -$57.3M -- -$23.6M -$84.7M
Repurchase of Common Stock -- -$2.4M -- -- --
Other Financing Activities $28.2M $2.4M -- $306M $168.2M
Cash From Financing -$138M -$91.4M -$265.6M $5M $113.4M
 
Beginning Cash (CF) $1.3B $989.5M $1.9B $1.1B $809.5M
Foreign Exchange Rate Adjustment $40.8M $3.7M -- -- $1.3M
Additions / Reductions -$260.6M $130.4M -$142.1M -$327.2M $10.4M
Ending Cash (CF) $1.1B $1.1B $1.7B $806.2M $820M
 
Levered Free Cash Flow -$267.6M $210.8M $122M -$316M -$269.8M
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders -$747.9M $425M $824.8M $20.1M -$56.4M
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- $55.4M
Change in Inventories -- -- -- -- -$87.4M
Cash From Operations $367.5M $744.9M $1B $184.9M -$135.3M
 
Capital Expenditures $179.5M $112.1M $611.5M $994.7M $644.8M
Cash Acquisitions -- -- $37.8M $473.5K -$140.4K
Cash From Investing -$420.5M -$332.2M -$528.1M -$602.9M -$329M
 
Dividends Paid (Ex Special Dividend) -$4.6M -$4.7M -$76.7M -$109M -$46.3M
Special Dividend Paid
Long-Term Debt Issued $1.6B $139.9M $175.6M $1.5B $910.7M
Long-Term Debt Repaid -$531M -$1.4B -$415.9M -$1.2B -$538.1M
Repurchase of Common Stock -$4.7M -$9.1M -$7.2M -$10.8M -$5.3M
Other Financing Activities -$12.3M $18.9M $190.3M $270.7M -$255.5M
Cash From Financing $1B -$1.2B -$69.5M $289.2M -$7.5M
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $998.4M -$771.8M $379.2M -$53.4M -$495.3M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $188M $632.8M $418.5M -$809.7M -$780.2M
Period Ending 2021-05-22 2022-05-22 2023-05-22 2024-05-22
Net Income to Stockholders -- -- -- -- --
Depreciation & Amoritzation -- -- -- -- --
Stock-Based Compensation -- -- -- -- --
Change in Accounts Receivable -- -- -- -- --
Change in Inventories -- -- -- -- --
Cash From Operations -- -- -- -- --
 
Capital Expenditures -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Cash From Investing -- -- -- -- --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- -- -- -- --
Long-Term Debt Repaid -- -- -- -- --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash From Financing -- -- -- -- --
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions -- -- -- -- --
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow -- -- -- -- --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
RGC alert for May 21

Regencell Bioscience Holdings [RGC] is down 3.24% over the past day.

Buy
64
AKRO alert for May 21

Akero Therapeutics [AKRO] is up 1.56% over the past day.

Buy
76
AGYS alert for May 21

Agilysys [AGYS] is down 1.32% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock